Trial Profile
Prognostic Assessment of Contrast Echocardiography (PACE Study): An Observational Follow-up Study of Patients With Chest Pain Evaluated With AI-700 Contrast Echocardiography
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 06 Jun 2014
Price :
$35
*
At a glance
- Drugs Perflubutane (Primary)
- Indications Coronary artery disease
- Focus Diagnostic use
- Acronyms PACE
- Sponsors Acusphere
- 06 Jun 2014 New trial record